MagCath

📍 Copenhagen, Denmark👥 5 employees💰 Last funded Jul 2024
Medical Equipment Manufacturing🌐 magcath.com
Website LinkedIn
We are on a mission to help women suffering from stress urinary incontinence. We have developed a groundbreaking solution to address this global issue. Our unique product, Obtinu®, is a patented and clinically proven medical device designed to provide effective assistance to women experiencing stress urinary incontinence. This innovative solution offers a safe, efficient, and simple way to regain continence and reclaim an active lifestyle. With more incontinence pads sold than diapers, the need for a solution like Obtinu® has never been more evident. Join us as we lead the way in empowering women and revolutionizing the approach to stress urinary incontinence.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in MagCath?
MagCath has 1 investors on record on gritt.io.
When did MagCath last raise funding?
The most recent investment in MagCath recorded on gritt.io was in July 2024.
What industry is MagCath in?
MagCath operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is MagCath based?
MagCath is headquartered in Copenhagen, Denmark.